Overview of NDC 76282-0250
NDC 76282-0250 corresponds to Escitalopram oxalate, a film-coated oral tablet manufactured by Exelan Pharmaceuticals Inc. This drug is a serotonin reuptake inhibitor, commonly used to treat depression and generalized anxiety disorder[1][5].
Market Context
Global Pharmaceutical Market Trends
The pharmaceutical market is characterized by significant price disparities across different regions. In the U.S., the average price per unit of drugs is substantially higher compared to other OECD countries and the rest of the world. For instance, in 2022, the average price per unit in the U.S. was 5.5 times higher than in OECD countries (excluding the U.S.) and 7.7 times higher than in the rest of the world[4].
Sales Revenue Trends
In the U.S., sales revenues for pharmaceuticals have shown notable growth. Between 2017 and 2022, U.S. sales revenues for retail and non-retail markets grew by 22% and 26%, respectively. In contrast, retail markets in the rest of the world and OECD countries (excluding the U.S.) experienced declines of 6% and 4%, respectively, while non-retail markets saw growth of 13% and 12%[4].
Pricing Dynamics
Current Pricing
As of recent data, the pricing for Escitalopram oxalate (NDC 76282-0250) is influenced by various factors, including market competition and regulatory environments. The price per unit can vary based on the vendor, quantity, and other market conditions. For example, prices for similar drugs from Exelan Pharmaceuticals have shown fluctuations over time, reflecting broader market trends[2].
Historical Price Trends
Historical data indicates that prices for pharmaceuticals in the U.S. have been increasing. Between 2017 and 2022, the average price per unit for all drugs in the U.S. increased by 14%, while prices in other OECD countries and the rest of the world decreased by 9% and 7%, respectively[4].
Price Projections
Short-Term Projections
Given the current trends, it is likely that the price of Escitalopram oxalate will continue to be influenced by the overall increase in pharmaceutical prices in the U.S. market. However, the rate of increase may be moderated by competition from generic drugs and regulatory pressures.
Long-Term Projections
In the long term, several factors will shape the pricing of Escitalopram oxalate:
- Market Competition: Increased competition from generic versions and other antidepressants could lead to price stabilization or even a slight decrease.
- Regulatory Changes: Any changes in regulatory policies or healthcare reforms could impact pricing strategies.
- Economic Factors: Economic conditions, such as inflation and changes in healthcare spending, will also influence pricing.
Impact of Technological and Data Trends
Role of AI and Health Tech
The adoption of artificial intelligence (AI) and health technology is expected to grow significantly in the pharmaceutical industry. AI can help in optimizing clinical trials, predicting market trends, and improving drug development processes. This could lead to more efficient and cost-effective drug production, potentially influencing pricing[3].
Use of External Data
Pharmaceutical companies are increasingly relying on external data to train their internal data science models. This trend could enhance the accuracy of market predictions and pricing strategies, helping companies like Exelan Pharmaceuticals to make more informed decisions[3].
Key Players and Market Share
Exelan Pharmaceuticals Inc. is a significant player in the generic pharmaceutical market, with a diverse portfolio of drugs including Escitalopram oxalate. The company's market share is influenced by its ability to compete with other generic and branded drug manufacturers.
Consumer and Prescriber Behavior
Consumer and prescriber behavior play crucial roles in the demand for Escitalopram oxalate. Factors such as patient preference, prescriber habits, and insurance coverage can affect the sales volume and pricing of the drug.
Regulatory Environment
The regulatory environment, including FDA approvals and compliance requirements, significantly impacts the pricing and availability of pharmaceuticals. Any changes in regulatory policies can affect the market dynamics and pricing strategies for drugs like Escitalopram oxalate.
Conclusion
The market analysis and price projections for NDC 76282-0250, Escitalopram oxalate, are influenced by a complex interplay of global market trends, regulatory environments, technological advancements, and consumer behavior. While prices are likely to continue increasing in the short term due to broader U.S. market trends, long-term projections suggest that competition, regulatory changes, and technological advancements could moderate or even reduce prices.
Key Takeaways
- Global Price Disparities: The U.S. market has significantly higher drug prices compared to other regions.
- Market Growth: U.S. sales revenues for pharmaceuticals have grown substantially, while other regions have seen declines in retail markets.
- Technological Impact: AI and health tech are expected to enhance efficiency and potentially influence pricing.
- Regulatory Influence: Changes in regulatory policies can significantly impact pricing and market dynamics.
- Competition and Consumer Behavior: Market competition and consumer/prescriber behavior are crucial in determining demand and pricing.
FAQs
Q: What is the current market trend for pharmaceutical prices in the U.S.?
A: The current market trend shows an increase in pharmaceutical prices in the U.S., with a 14% increase in average price per unit between 2017 and 2022[4].
Q: How does AI impact the pharmaceutical industry?
A: AI is expected to enhance clinical trial efficiency, improve drug development processes, and help in predicting market trends, which could influence pricing and market strategies[3].
Q: What factors influence the pricing of Escitalopram oxalate?
A: Pricing is influenced by market competition, regulatory environments, technological advancements, and consumer/prescriber behavior.
Q: How does the regulatory environment affect pharmaceutical pricing?
A: Changes in regulatory policies can significantly impact pricing and market dynamics by affecting the approval and compliance requirements for drugs.
Q: What is the role of external data in pharmaceutical companies?
A: External data is increasingly used to train internal data science models, enhancing the accuracy of market predictions and pricing strategies[3].
Sources
- FDA.report: NDC 76282-250 Oral Tablet, Film Coated Escitalopram oxalate.
- DrugPatentWatch: Latest drug prices and trends for NDC 76282-0572.
- Intelligencia.ai: 2025 Pharma Predictions: AI, Health Tech, and Data Trends to Watch.
- ASPE: ISSUE BRIEF - International Market Size and Prices.
- FindACode: EXELAN PHARMACEUTICALS, INC. - List of Drugs - NDC Labeler.
